Loading...

PODD INSULET CORP Other Situations 8-K Filing

NSLT

PDD

INSULET CORP

(PODD)

2026 8-K

Financial Results Released

Device Correction Update

Medical Device Correction

Severance Agreement

Stock Buyback Increase

Material Agreement Update

Accountant Change

Incentive Plan Revision

Financial Results

Board Appointment

CFO Appointment

Financial Statements

Debt Restructuring

Financial Statements

Management Change

Management Change

Contract Extension

Equity Agreement Update

Financial Results

Q3 Financial Results

Earnings Reports

Credit Agreement Amendment

Earnings Reports

Annual Meeting of Stockholders

Agreement Extension

Earnings Reports

Appointment of CFO

Compensatory Arrangements o...

Earnings Reports

Credit Agreement Amendment

Appointment of Directors an...

Earnings Reports

Resignation of CFO

Earnings Reports

Credit Agreement Amendment

Amendment to Supply Agreement

Annual Meeting of Stockholders

Departure of Chief Commerci...

Earnings Reports

Earnings Reports

Equity Agreements and Manag...

Agreement with Bigfoot Biom...

External Links:

On March 12, 2026, Insulet Corporation announced a voluntary medical device correction expected to cost up to $40 million in 2026 but maintained its prior guidance. This filing indicates a significant event for the company regarding compliance and operational adjustments.

AI Assistant

INSULET CORP

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.